SOSTDC1 and thyroid cancer: For example, a study by Zhou et al. (2017) showed that Sostdc1 compromised the migratory and invasive properties and epithelial-mesenchymal transition (EMT) activity of follicular thyroid cancer cells by suppressing the activities of the PI3K/Akt and MAPK/ERK signalling pathways.